Hypoxic-inflammatory Responses Under Acute Hypoxia: In Vitro Experiments and Prospective Observational Expedition Trial
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Induction of hypoxia-inducible-factor-1α (HIF-1α) pathway and HIF-target genes allow adaptation to hypoxia and are associated with reduced incidence of acute mountain sickness (AMS). Little is known about HIF-pathways in conjunction with inflammation or exercise stimuli under acute hypobaric hypoxia in non-acclimatized individuals. We therefore tested the hypotheses that 1) both hypoxic and inflammatory stimuli induce hypoxic-inflammatory signaling pathways in vitro, 2) similar results are seen in vivo under hypobaric hypoxia, and 3) induction of HIF-dependent genes is associated with AMS in 11 volunteers. In vitro, peripheral blood mononuclear cells (PBMCs) were incubated under hypoxic (10%/5% O) or inflammatory (CD3/CD28) conditions. In vivo, Interleukin 1β (IL-1β), C-X-C Chemokine receptor type 4 (CXCR-4), and C-C Chemokine receptor type 2 (CCR-2) mRNA expression, cytokines and receptors were analyzed under normoxia (520 m above sea level (a.s.l.)), hypobaric hypoxia (3883 m a.s.l.) before/after exercise, and after 24 h under hypobaric hypoxia. In vitro, isolated hypoxic ( = 0.004) or inflammatory ( = 0.006) stimuli induced IL-1β mRNA expression. CCR-2 mRNA expression increased under hypoxia ( = 0.005); CXCR-4 mRNA expression remained unchanged. In vivo, cytokines, receptors, and IL-1β, CCR-2 and CXCR-4 mRNA expression increased under hypobaric hypoxia after 24 h (all ≤ 0.05). Of note, proinflammatory IL-1β and CXCR-4 mRNA expression changes were associated with symptoms of AMS. Thus, hypoxic-inflammatory pathways are differentially regulated, as combined hypoxic and exercise stimulus was stronger in vivo than isolated hypoxic or inflammatory stimulation in vitro.
High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.
Yang X, Liu H, Wu X Clin Exp Med. 2025; 25(1):79.
PMID: 40063280 PMC: 11893705. DOI: 10.1007/s10238-025-01577-3.
Riou M, Charles A, Enache I, Evrard C, Pistea C, Giannini M Int J Mol Sci. 2025; 26(2).
PMID: 39859418 PMC: 11765662. DOI: 10.3390/ijms26020705.
Pignatelli P, Mrakic-Sposta S, Bondi D, DAntonio D, Piattelli A, Santangelo C J Clin Med. 2024; 13(20).
PMID: 39458216 PMC: 11508378. DOI: 10.3390/jcm13206266.
Yan J, Zhang Z, Ge Y, Chen J, Gao Y, Zhang B Int J Mol Sci. 2024; 25(20).
PMID: 39457093 PMC: 11508554. DOI: 10.3390/ijms252011311.
Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets.
Nisar A, Khan S, Li W, Hu L, Samarawickrama P, Gold N MedComm (2020). 2024; 5(11):e786.
PMID: 39415849 PMC: 11480526. DOI: 10.1002/mco2.786.